Siddiqui Tuba, Muhammad Iyad Naeem, Khan Muhammad Naseem, Fatima Sakina, Alam Nausheen, Masood Rida, Saeed Rehana, Naqvi Ghazala Raza, Naqvi Talat
Department of Pharmaceutics, Faculty of Pharmacy & Pharmaceutical Sciences, University of Karachi, Karachi, Pakistan.
Food & Marine Resources Research Centre PCSIR Laboratory Complex Karachi.
Pak J Pharm Sci. 2018 Sep;31(5(Supplementary)):2091-2094.
Among resistant nosocomial and community pathogens, MRSA has become the most serious pathogen, causing life threatening infections worldwide. In S.aureus, quick and exact recognition of methicillin (cefoxitin) resistance has become essential. The benchmark for MRSA identification among S.aureus is the detection of the mecA gene that causes the expression of protein (PBP2a) culpable for classic β-lactam resistance. However, the utter reliance on amplification of mecA gene as a hallmark in confirmation of methicillin (cefoxitin) resistant S. aureus is the matter of distrust by some investigators. The current investigation designed to analyse the prevalence of mecA gene among phenotypically positive MRSA isolates using molecular method and to correlate its prevalence to conventional techniques. Furthermore, antimicrobial sensitivity of mecA positive staphylococci was determined by Kirby Baeuer method. For this purpose, 201 clinical staphylococcal specimens were recovered from various diagnostic laboratories in Karachi City, Pakistan. Phenotypic existence of methicillin resistance in S. aureus was observed to be 51.7%. In contrast, when organisms were subjected for amplification of mecA gene by PCR, mecA positive isolates were 36/104 (35%) MRSA isolates. Current work raise question towards the usefulness of molecular identification of mecA gene in confirmation of methicillin resistance without correlating with conventional methods. Therefore, it is essential to consider the other possible resistance mechanisms for β-lactams that may interact with mecA gene in the development of methicillin resistance mechanism in Staphylococcus.
在耐药的医院和社区病原体中,耐甲氧西林金黄色葡萄球菌(MRSA)已成为最严重的病原体,在全球范围内引起危及生命的感染。在金黄色葡萄球菌中,快速准确地识别对甲氧西林(头孢西丁)的耐药性已变得至关重要。金黄色葡萄球菌中MRSA鉴定的基准是检测导致对经典β-内酰胺耐药的蛋白质(PBP2a)表达的mecA基因。然而,一些研究人员对完全依赖扩增mecA基因作为确认耐甲氧西林(头孢西丁)金黄色葡萄球菌的标志表示怀疑。本研究旨在使用分子方法分析表型阳性的MRSA分离株中mecA基因的流行情况,并将其流行率与传统技术相关联。此外,通过 Kirby Baeuer 方法测定mecA阳性葡萄球菌的抗菌敏感性。为此,从巴基斯坦卡拉奇市的各个诊断实验室收集了201份临床葡萄球菌标本。观察到金黄色葡萄球菌中耐甲氧西林的表型存在率为51.7%。相比之下,当通过PCR对菌株进行mecA基因扩增时,mecA阳性分离株为36/104(35%)的MRSA分离株。当前的研究对在不与传统方法相关联的情况下通过分子鉴定mecA基因来确认耐甲氧西林性的实用性提出了质疑。因此,有必要考虑其他可能与mecA基因相互作用以在金黄色葡萄球菌耐甲氧西林机制发展中发挥作用的β-内酰胺耐药机制。